Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey
- PMID: 24998933
- PMCID: PMC4399234
- DOI: 10.1016/j.atherosclerosis.2014.06.009
Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey
Abstract
Objective: Leptin and C-reactive protein (CRP) have each been linked to adverse cardiovascular events, and prior cross-sectional research suggests that increased levels of both biomarkers pose an even greater risk. The effect of increased levels of both leptin and CRP on mortality has not, however, been previously assessed.
Methods: We used data from the third National Health and Nutrition Examination Survey (NHANES III) to estimate the mortality effect of high leptin and high CRP levels. Outcomes were compared with the use of inverse-probability-weighting adjustment. Among 6259 participants included in the analysis, 766 were in their sex-specific, population-weighted highest quartiles of both leptin and CRP. Median follow-up time was 14.3 years.
Results: There was no significant difference in adjusted all-cause mortality between the groups (risk ratio 1.22, 95% confidence interval [CI], 0.97-1.54). Similar results were noted with the use of several different analytic methods and in many subgroups, though high leptin and CRP levels may increase all-cause mortality in males (hazard ratio, 1.80, 95% CI, 1.32-2.46; P for interaction, 0.011). A significant difference in cardiovascular mortality was also noted (risk ratio, 1.54, 95% CI, 1.08-2.18), though that finding was not confirmed in all sensitivity analyses..
Conclusions: In this observational study, no significant difference in overall all-cause mortality rates in those with high leptin and high CRP levels was found, though high leptin and CRP levels appear associated with increased mortality in males. High leptin and CRP levels also likely increase risk for cardiovascular death..
Keywords: Atherosclerosis; C-reactive protein; Cardiovascular diseases; Epidemiology; Leptin.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Figures

Similar articles
-
Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):418-25. doi: 10.1038/ncpcardio1218. Epub 2008 Apr 22. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18431365
-
The predictive role of the hs-CRP/HDL-C ratio for long-term mortality in the general population: evidence from a cohort study.BMC Cardiovasc Disord. 2024 Dec 30;24(1):758. doi: 10.1186/s12872-024-04446-1. BMC Cardiovasc Disord. 2024. PMID: 39736563 Free PMC article.
-
C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey.BMJ Open. 2019 Aug 30;9(8):e029861. doi: 10.1136/bmjopen-2019-029861. BMJ Open. 2019. PMID: 31473619 Free PMC article.
-
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.Atherosclerosis. 2017 Apr;259:75-82. doi: 10.1016/j.atherosclerosis.2017.02.003. Epub 2017 Feb 9. Atherosclerosis. 2017. PMID: 28327451 Review.
-
Biomarkers related to aging in human populations.Adv Clin Chem. 2008;46:161-216. doi: 10.1016/s0065-2423(08)00405-8. Adv Clin Chem. 2008. PMID: 19004190 Free PMC article. Review.
Cited by
-
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.PLoS One. 2021 Jul 2;16(7):e0254198. doi: 10.1371/journal.pone.0254198. eCollection 2021. PLoS One. 2021. PMID: 34214138 Free PMC article.
-
Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease.Ther Clin Risk Manag. 2018 Oct 1;14:1855-1862. doi: 10.2147/TCRM.S172231. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30319266 Free PMC article.
-
Serum leptin, C-reactive protein, and cancer mortality in the NHANES III.Cancer Med. 2016 Jan;5(1):120-8. doi: 10.1002/cam4.570. Epub 2015 Dec 2. Cancer Med. 2016. PMID: 26632325 Free PMC article.
-
The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.Osteoporos Int. 2017 Aug;28(8):2475-2483. doi: 10.1007/s00198-017-4068-2. Epub 2017 May 13. Osteoporos Int. 2017. PMID: 28501890
-
A Clinical Perspective: Contribution of Dysfunctional Perivascular Adipose Tissue (PVAT) to Cardiovascular Risk.Curr Hypertens Rep. 2016 Nov;18(11):82. doi: 10.1007/s11906-016-0692-z. Curr Hypertens Rep. 2016. PMID: 27787838 Review.
References
-
- Misra A, Garg A. Leptin, its receptor and obesity. J Investig Med. 1996;44(9):540–8. - PubMed
-
- Lönnqvist F. The obese (ob) gene and its product leptin—a new route toward obesity treatment in man? QJM. 1996;89(5):327–332.
-
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32. - PubMed
-
- Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens. 2004;13(2):215–23. - PubMed
-
- Sharma V, McNeill JH. The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology. Curr Vasc Pharmacol. 2005;3(2):169–80. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous